首页> 外文期刊>Emerging Infectious Diseases >Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France (http://wwwnc.cdc.gov/eid/article/20/9/13-1668)
【24h】

Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France (http://wwwnc.cdc.gov/eid/article/20/9/13-1668)

机译:法国有或没有艾滋病患者的吉氏肺孢子虫肺炎(http://wwwnc.cdc.gov/eid/article/20/9/13-1668)

获取原文
获取外文期刊封面目录资料

摘要

Pneumocystis jirovecii pneumonia (PCP) in patients without AIDS is increasingly common. We conducted a prospective cohort study of consecutive patients with proven PCP; of 544 patients, 223 (41%) had AIDS (AIDS patients) and 321 (59%) had other immunosuppressive disorders (non-AIDS patients). Fewer AIDS than non-AIDS patients required intensive care or ventilation, and the rate of hospital deaths—17.4% overall—was significantly lower for AIDS versus non-AIDS patients (4% vs. 27%; p<0.0001). Multivariable analysis showed the odds of hospital death increased with older age, receipt of allogeneic bone marrow transplant, immediate use of oxygen, need for mechanical ventilation, and longer time to treatment; HIV-positive status or receipt of a solid organ transplant decreased odds for death. PCP is more often fatal in non-AIDS patients, but time to diagnosis affects survival and is longer for non-AIDS patients. Clinicians must maintain a high index of suspicion for PCP in immunocompromised patients who do not have AIDS.
机译:无艾滋病的肺炎支原体肺炎(PCP)越来越普遍。我们对连续的经过证实的PCP患者进行了前瞻性队列研究。在544名患者中,有223名(41%)患有AIDS(艾滋病患者),而321名(59%)有其他免疫抑制性疾病(非AIDS患者)。需要重症监护或通气的艾滋病患者少于非艾滋病患者,而艾滋病的住院死亡率(总体为17.4%)显着低于非艾滋病患者(4%比27%; p <0.0001)。多变量分析显示,随着年龄的增长,同种异体骨髓移植的获得,立即使用氧气,需要机械通气以及治疗时间的延长,医院死亡的几率会增加; HIV阳性或接受实体器官移植可降低死亡几率。五氯苯酚在非艾滋病患者中更容易致命,但诊断时间会影响生存,对非艾滋病患者则更长。对于没有艾滋病的免疫功能低下的患者,临床医生必须高度怀疑PCP。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号